The present invention provides for compounds of Formula I and various embodiments thereof, and compositions comprising compounds of Formula I and various embodiments thereof.
In compounds of Formula I, the groups R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, m, n and the C-linked Ring have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula I as DLK inhibitors and for treating neurodegeneration diseases and disorders.
Scalable Photoelectrochemical Dehydrogenative Cross‐Coupling of Heteroarenes with Aliphatic C−H Bonds
作者:Pin Xu、Peng‐Yu Chen、Hai‐Chao Xu
DOI:10.1002/anie.202005724
日期:2020.8.17
of heteroarenes and C(sp3)−H donors through H2 evolution, without the addition of metal catalysts or chemical oxidants. Mechanistically, the C(sp3)−H donor is converted to a nucleophilic carbon radical through H‐atom transfer with chlorine atom, which is produced by light irradiation of anodically generated Cl2 from Cl−. The carbon radical then undergoes radical substitution to the heteroarene to afford